Delivery Order SPE2DB24D1205-SPE2DB25FCXHD

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,353.29, is for the delivery of DEXMETHYLPHENIDATE ER 25 MG CP 100S, a pharmaceutical product. The contract has a completion date of March 26, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,502.12, is a Delivery Order contract for the supply of DEXMETHYLPHENIDATE ER 30 MG CP 100S, a prescription medication. The contract has a ceiling value of $1,502.12 and an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,156.16 firm-fixed-price delivery order is for the supply of 4567603444 DEXMETHYLPHENIDATE ER 10 MG CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,644.76 firm fixed-price contract is for the delivery of DEXMETHYLPHENIDATE ER 5 MG CAP 100S, a specialty medication, with a period of performance through April 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of DEXMETHYLPHENIDATE ER 15 MG CP 100S. The contract has a ceiling value of $1,258.08 and an ultimate completion date of January 13, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that specializes in supplying medical products to federal government agencies, particularly within military and veterans'...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.48, is a delivery order for the supply of 4567887706 DEXMETHYLPHENIDATE ER 10 MG CP 100S. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. The contract is a Firm Fixed Price agreement, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXMETHYLPHENIDATE ER 25 MG CP 100S. The contract has a ceiling value of $1,081.76 and a period of performance through May 17, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract is for the supply of 4,564,184,989 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 20 MG CP 100S. The award has a ceiling value of $4,381.42 and a period of performance through April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,827.24 Firm Fixed Price Delivery Order covers the supply of 4567612809 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, with a completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXMETHYLPHENIDATE ER 30 MG CP 100S, a prescription medication, with a ceiling value of $1,004.38 and a period of performance through February 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCXHD
    Delivery Order

This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEXMETHYLPHENIDATE ER 20 MG CP. The contract has a ceiling value of $2,588.12 and a performance period ending on June 4, 2025. This award is not a set-aside contract.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:43 AM